Investing Profile

David Rubin

VCInvestor

Managing Director at Merck Global Health Innovation Fund

Your Intro Paths to David Rubin

Signal uses Gmail to reveal intro paths. Email content is never read.

Find David Rubin on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

David Rubin is on these Sector & Stage Rankings

David Rubin's Investments On Record (13)

Company	StageDateRound Size	Total Raised
Turbine	Series BFeb 2026$25M Series ANov 2022$21M	$160M
Co-investors: Barath Shankar Subramanian (Accel), Alexandre Perrin (Enauto Ventures), Anvesh Ramineni (MassMutual Ventures), Hany Nada (ACME Capital), Daniel Waterhouse (Balderton Capital), Esther Dyson (23andMe), Christian Dahlen (Band of Angels), Vishal Gulati (Molten Ventures), Richard De Silva
Octave	Series CSep 2025$36M Series BJul 2023$33M Series UnknownOct 2021	$190M
Co-investors: Mike Pellini (Section 32), Michael Rubin (Northpond Ventures), Julian Harris (Deerfield Management), Brett Queener (Bonfire Ventures), Saurabh Bhansali (Health Velocity Capital), Michael G. Rubin
N-Power Medicine	Series BMay 2024$72M	$72M
Baseimmune	Series AFeb 2024$11M	$17M
Co-investors: Jamie Macfarlane (Creator Fund), Hussein Kanji (Hoxton Ventures)
Culmination Bio	Series ANov 2023$10M	$10M
Co-investors: Jack Boren
PreciseDx	Series AJan 2022$11M	$14M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds)
Verge Genomics	Series BDec 2021$98M	$130M
Co-investors: Lan Xuezhao (Basis Set Ventures), Henry McNamara (Great Oaks Venture Capital), Andrew Boszhardt (Great Oaks Venture Capital), Jesse Beyroutey (IA Ventures), Elad Gil (Think Colorado), Chris Sklarin (Castor Ventures), Kimberly Vogel Reynik, Kimberly Vogel
Saama	Private EquityOct 2021